The targeted therapy, marketed as Elahere, has shown improved survival rates and better quality of life in women with advanced ovarian cancer that no longer responds to platinum-based chemotherapy.
A groundbreaking new study has found that India’s genetic structure is significantly different from Western populations, raising important questions about whether medicines and treatments...
